Helus Pharma Appoints Michael Halstead as Chief Executive Officer
Go back to Helus Pharma Appoints Michael Halstead as Chief Executive Officer| (NASDAQ: HELP) | Delayed: 11.67 +0.10 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.57 | 52 Week High | $ | |||
| Open | $11.56 | 52 Week Low | $ | |||
| Day High | $11.77 | P/E | N/A | |||
| Day Low | $11.17 | EPS | $ | |||
| Volume | 991,804 | |||||

